Symptom control NSAID Best evidence from rheumatoid arthritis Also good for cancer pain Effective in 5 out of 10 placebo-trials for LBP Effective in 4 out of 9 Panadol-trials for LBP Doubtful value for non-specific musculoskeletal pain Koes Ann Rheum. Dis. 1997 Eisenberg J clin. Onco. 1994
Symptom control NSAID Best evidence from rheumatoid arthritis Also good for cancer pain Effective in 5 out of 10 placebo-trials for LBP Effective in 4 out of 9 Panadol-trials for LBP Doubtful value for non-specific musculoskeletal pain Koes Ann. Rheum. Dis. 1997 Eisenberg J. Clin. Onco. 1994
Symptom control NSAID Annual gi bleed risk: 0.8-18%/year Annual death rate: 0.03-0. 1%/year Cervical cancer Asthma GI adverse effects Leukaemia Death rate(per 100,000) MacDonald BMJ1997
Symptom control NSAID Annual GI bleed risk: 0.8-18% / year Annual death rate: 0.03-0.1% / year MacDonald BMJ 1997
Symptom control NSAID Risk increase with age, >4 week use, history of Gi bleed /ulcer /CVs disease Least damaging: Ibuprofen Only effective prophylaxis: PPl womans N. Eng J Med. 1998
Symptom control NSAID Risk increase with age, > 4 week use, history of GI bleed / ulcer / CVS disease Least damaging: Ibuprofen Only effective prophylaxis: PPI Yeomans N. Eng. J. Med. 1998
Symptom control COX-2 specific NSAID You know what happened to your patients
Symptom control COX-2 specific NSAID You know what happened to your patients
Symptom control COX-2 specific NSAID MERCK CO INC Splits as of 13-Jan-2006 Sepo Copyright 2005 Yahoo! I ou know what happened to your shares?
Symptom control COX-2 specific NSAID You know what happened to your shares?